COPD Spotlight

Dr Antonio Anzueto on Current Developments to Address COPD

Antonio Anzueto, MD, recently spoke with The American Journal of Managed Care® (AJMC®) about some of the latest developments in chronic obstructive pulmonary disease (COPD). Anzueto is a professor of medicine and section chief of pulmonary at South Texas Veterans Healthcare System, an affiliated institution with the University of Texas Health San Antonio, Texas.

Dr Antonio Anzueto on the Ties Between COPD, Cardiovascular Disease

Antonio Anzueto, MD, recently spoke with The American Journal of Managed Care® (AJMC®) about the latest advances in therapy for chronic obstructive pulmonary disease (COPD), as well as what is known about the relationship between COPD and cardiovascular disease. Anzueto is a professor of medicine and section chief of pulmonary at South Texas Veterans Healthcare System, an affiliated institution with the University of Texas Health San Antonio, Texas.

Dr Sanjay Sethi on How Social Determinants of Health Affect Outcomes in Patients With COPD

In this interview, Sanjay Sethi, MD, professor and chief, Pulmonary, Critical Care and Sleep Medicine; assistant vice president for Health Sciences, Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York, discusses the complications of managing patients with multiple comorbidities that are not preventable.

Dr Sanjay Sethi on the Economic Burdens of Chronic Obstructive Pulmonary Disease

There is a need for continuous education for patients and providers in order to better diagnose and manage chronic obstructive pulmonary disease (COPD), according to Sanjay Sethi, MD, professor and chief, Pulmonary, Critical Care and Sleep Medicine; assistant vice president for Health Sciences, Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York,

Dr Fernando Martinez on COPD’s Health Care Impact and the Case for Earlier Treatment

Fernando Martinez, MD, MS, chief of the Pulmonary and Critical Care Medicine Division, Weill Cornell Medicine, New York, continues a conversation about the updates in the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).

Dr Fernando Martinez Explains 2023 GOLD Guideline Updates for COPD

In this interview, Fernando Martinez, MD, MS, chief of the Pulmonary and Critical Care Medicine Division, Weill Cornell Medicine, New York, discusses the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).

Inadequate Device Use a Challenge in COPD Management, Dr David Mannino Explains

The therapies to treat chronic obstructive pulmonary disease (COPD) include devices with instructions for use, which are far more complicated than simply smoking a cigarette.

Dr Courtney Crim Outlines Creating Personalized Treatment Regimens for COPD

There are various treatments on the market for patients with chronic obstructive pulmonary disease (COPD), all with their own pros and cons to be considered as part of a personalized treatment regimen.

Michael Hess Reviews Treatments for COPD and Assessing the Effectiveness of Therapies

Respiratory therapist Michael Hess, MPH, RRT, RPFT, discusses the main therapies used for chronic management of chronic obstructive pulmonary disorder (COPD), as well as the decision to escalate to triple therapy.

Dr Nicola Hanania on the Future of COPD Research

Assessing Patient-Reported Treatment Values in COPD

COPD & Social Determinants of Health: An Interview With Dr Trisha Parekh

Dr Gerard Criner Offers Insights on Early COPD Diagnosis, Next Steps for Triple Therapy

Dr Antonio Anzueto on the Benefits of Triple Therapy, Importance of Accurate COPD Diagnoses

COPD & COVID-19: An Interview With Dr MeiLan Han